ArticleClinical epigenetics2022

Bisulfite profiling of the MGMT promoter and comparison with routine testing in glioblastoma diagnostics.

Sascha Tierling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.